Gender-related affecting factors of prediabetes on its 10-year outcome

BMJ Open Diabetes Research and Care

Volumn 4, Issue 1, 2016, Pages

  Song, Xiaomin ^a   Qiu, Miaoyan ^a   Zhang, Xuan'e ^b   Wang, Haiyan ^c   Tong, Wenxin ^a   Ju, Liping ^a   Gu, Lei ^b   Sun, Siming ^d   Zhang, Hongli ^d   Wang, Weiqing ^a   Tian, Jingyan ^a,d  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Tongji University School of Medicine   (China)

^c Ping Liang Community Health Service Center   (China)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EDUCATION; FEMALE; FOLLOW UP; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC EQUIVALENT; METABOLIC REGULATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84991518357     PISSN: None     EISSN: 20524897     Source Type: Journal    
DOI: 10.1136/bmjdrc-2015-000169     Document Type: Article

References (31)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
2. Bullard KM, Saydah SH, Imperatore G, et al. Secular changes in U. S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010. Diabetes Care 2013;36:2286-2293.
3. Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948-959.
4. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
5. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among participants with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
6. Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-161.
7. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-2077.
8. Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006;368:1096-1105.
9. Legato MJ, Gelzer A, Goland R, et al. Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 2006;3:131-158.
10. Arnetz L, Ekberg NR, Alvarsson M. Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes 2014;7:409-420.
11. Perreault L, Færch K. Approaching pre-diabetes. J Diabetes Complicat 2014;28:226-233.
12. Meigs JB, Muller DC, Nathan DM, et al. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 2003;1452:1475-84.
13. Perreault L, Kahn SE, Christophi CA, et al. Regression from pre-diabetes to normal glucose regulation in the Diabetes Prevention Program. Diabetes Care 2009;32:1583-1588.
14. Tian JY, Cheng Q, Song XM, et al. Birth weight and risk of type 2 diabetes, abdominal obesity and hypertension among Chinese adults. Eur J Endocrinol 2006;155:601-607.
15. Qiu M, Shen W, Song X, et al. Effects of prediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellitus: longitudinal study. Hypertension 2015;65:525-530.
16. Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc 2011;43:1575-1581.
17. Escobar-Jiménez F, Herrera Pombo JL, Gómez-Villalba R, et al. Standard breakfast test: an alternative to glucagon testing for C-peptide reserve? Horm Metab Res 1990;22:339-341.
18. Liao YQ. Clinical application of standard steamed bread test in diabetes diagnosis. Clin Lab J 2012;4:242-246.
19. Zhang HJ, Ji LN. Effects of oral glucose tolerance test and steamed bread test on glucose metabolism and diabetic ketoacidosis in patients with type 2 diabetes mellitus. Chin J Diab 2003;1:48-50.
20. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-S69.
21. Ramachandran A, Snehalatha C, Mary S, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-297.
22. Del Prato S, Bianchi C, Miccoli R, et al. Pharmacological intervention in prediabetes: considering the risks and benefits. Diabetes Obes Metab 2007;9(Suppl 1):17-22.
23. Forouhi NG, Luan J, Hennings S, et al. Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet Med 2007;24:200-207.
24. Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753-759.
25. Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677-1686.
26. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008;371:1783-1789.
27. Kim MK, Jang EH, Son JW, et al. Visceral obesity is a better predictor than generalized obesity for basal insulin requirement at the initiation of insulin therapy in patients with type 2 diabetes. Diabetes Res Clin Pract 2011;93:174-178.
28. Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005;81:555-563.
29. Wei M, Gaskill SP, Haffner SM, et al. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans—a 7-year prospective study. Obes Res 1997;5:16-23.
30. Dutta D, Choudhuri S, Mondal SA, et al. Urinary albumin: creatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: role of associated insulin resistance, inflammatory cytokines and low vitamin D. J Diabetes 2014;6:316-322.
31. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26: 3160-3167.